Specialty code 390200000X · New Haven, CT
NPI
1336414630
Since 2012
Specialty
Specialty code 390200000X
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
333 Cedar St, Room Www211
New Haven, CT, 06510
Phone (203) 785-5196
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$5.3M
806 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Alice C Li prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 157 prescriptions and refills. In total Alice C Li wrote 806 Medicare prescriptions that cost $5.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Tagrisso Osimertinib Mesylate | 157 | 157 | 16 | $2.6M |
| Dexamethasone Generic | 63 | 69 | 29 | $772 |
| Alecensa Alectinib Hcl | 52 | 52 | Under 11 | $827K |
| Ondansetron Hcl Generic | 50 | 50 | 31 | $409 |
| Prochlorperazine Maleate Generic | 47 | 47 | 32 | $678 |
| Lumakras Sotorasib | 42 | 42 | Under 11 | $529K |
| Anastrozole Generic | 28 | 85 | 15 | $792 |
| Gilotrif Afatinib Dimaleate | 25 | 25 | Under 11 | $319K |
| Prednisone Generic | 23 | 34 | 15 | $209 |
| Lorazepam Generic | 21 | 21 | 11 | $159 |
| Abiraterone Acetate Generic | 21 | 24 | Under 11 | $3,408 |
| Oxycodone Hcl Generic | 17 | 17 | 13 | $212 |
| Tabrecta Capmatinib Hydrochloride | 16 | 16 | Under 11 | $336K |
| Kisqali Ribociclib Succinate | 13 | 13 | Under 11 | $224K |
| Ondansetron Odt Ondansetron | 12 | 12 | Under 11 | $117 |
Brand drugs: 362 claims; generic drugs: 444 claims; opioid claims: 37.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Alice C Li were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.